What are you doing this week?
What are you doing this week? Feel free to share! Keep in mind it’s OK to do nothing at all, too.
We haven't written up this one. Lobsters has the full story — the link below goes straight to it.
What's breaking now, across thousands of outlets.
What are you doing this week? Feel free to share! Keep in mind it’s OK to do nothing at all, too.
We haven't written up this one. Lobsters has the full story — the link below goes straight to it.
With no background in coding , Faith Maeba, a psychology major, was reluctant when her mother first suggested she enroll in classes on artificial intelligence . But the senior at Virginia Commonwealth University began to see it differently as she looked into graduate psychology programs that explore human behavior in the workplace, which…
Shares of the Seattle-headquartered e-commerce and cloud giant had surged 15% on Friday after the company reported its fastest cloud revenue growth in over four years and increased its forecast for annual capital expenditure.
The U.S. Treasury joined efforts in Tokyo to stem the yen’s slide against the dollar, highlighting the broader risks posed by turmoil in Japanese markets.
On this episode of Stock Movers: - Bristol-Myers Squibb (SQB) shares are surging on news AstraZeneca (AZN), whose shares are lower, is exploring an acquisition of Bristol-Myers Squibb.
Mubadala is committing $170 billion, or roughly 44 per cent of its portfolio, to US interests, with investments across AI, semiconductors, health care, energy and advanced manufacturing, the Abu Dhabi sovereign wealth fund said on Monday.